Are you considering investing in Anthem Biosciences and looking for a detailed forecast of its share price? You’re at the right place. This page offers a comprehensive overview of Anthem Biosciences share price targets from 2025 to 2050, along with a complete fundamental analysis, financials, and business insights to support your investment decisions.
About Anthem Biosciences Ltd
Anthem Biosciences Limited is a leading Contract Research, Development, and Manufacturing Organization (CRDMO), founded in 2006. Headquartered in Bangalore, India, the company operates two state-of-the-art campuses with the capacity to accommodate over 1,000 researchers. The company specializes in developing and manufacturing new chemical and biological entities, supporting more than 150 global clients across over 200 projects.
Anthem provides end-to-end solutions in drug discovery, development, and manufacturing, serving biotech firms and major pharmaceutical companies. The company excels in the production of:
- Proteins and monoclonal antibodies
- Peptides, small and large molecules
- Toxins, nutritional and wellness products
With a strong focus on regulatory compliance, Anthem is regularly inspected by global authorities including USFDA, PMDA (Japan), and EU QPs. Its facilities include GMP kilo labs, pilot plants, and large-scale manufacturing units to support projects from milligram scale to multiple tons.
Key Management:
- Ajay Bharadwaj – CEO
- Ganesh Sambasivam – CSO
- K. Ravindra Chandrappa – COO
Anthem Biosciences Share Price Target 2025
According to our analysis, the projected share price of Anthem Biosciences in 2025 could range between ₹730 and ₹800.
Monthly Breakdown (2025):
| Month | Target Price |
|---|---|
| July | ₹730 |
| August | ₹745 |
| September | ₹760 |
| October | ₹775 |
| November | ₹790 |
| December | ₹800 |
This gradual increase reflects the company’s strong project pipeline, client base expansion, and steady earnings growth.
Anthem Biosciences Share Price Target 2026
In 2026, Anthem’s share price is expected to continue its upward momentum. Based on forecasted earnings and margin expansion, the projected range is ₹790 to ₹870.
| Month | Target Price |
|---|---|
| January | ₹790 |
| December | ₹870 |
Anthem Biosciences Share Price Target 2027
With expanding capacity and more biologics entering commercial phases, the 2027 share price may range from ₹850 to ₹950.
| Month | Target Price |
|---|---|
| January | ₹850 |
| December | ₹950 |
Anthem Biosciences Share Price Target 2028
By 2028, the share price could reach ₹1,020, with a base target of ₹940—driven by increased export orders and repeat contracts.
| Month | Target Price |
|---|---|
| January | ₹940 |
| December | ₹1,020 |
Anthem Biosciences Share Price Target 2029
If growth continues steadily, we expect Anthem’s 2029 share price to range from ₹1,000 to ₹1,200.
| Month | Target Price |
|---|---|
| January | ₹1,000 |
| December | ₹1,200 |
Anthem Biosciences Share Price Target 2030
By 2030, the projected share price could reach a maximum of ₹1,300, with a conservative floor of ₹1,190—supported by increased capacity utilization and deeper global partnerships.
| Month | Target Price |
|---|---|
| January | ₹1,190 |
| December | ₹1,300 |
Anthem Biosciences Fundamentals (FY2024)
| Fundamental Metric | Value |
|---|---|
| Market Cap | ₹0.00 Cr |
| EPS (Earnings/Share) | ₹9.01 |
| ROE (Return on Equity) | 20.47% |
| P/E Ratio | 0.00 |
| Book Value | ₹44.05 |
| P/B Ratio | 0.00 |
| Debt-to-Equity | 0.05 |
| Dividend Yield | 0.00% |
| Industry P/E | 43.16 |
| Face Value | ₹2 |
Anthem Biosciences Financial Report (FY2024)
| Financial Metric | Value |
|---|---|
| Revenue | ₹1,488 Cr |
| Expenses | ₹1,003 Cr |
| Profit Before Tax | ₹484.77 Cr |
| Net Profit | ₹374.78 Cr |
Anthem Biosciences Shareholding Pattern
| Shareholder Category | Percentage |
|---|---|
| Promoters | 74.69% |
| Retail & Others | 20.46% |
| FII | 1.50% |
| DII | 1.14% |
| Mutual Funds | 2.21% |
A strong promoter holding (over 74%) reflects confidence in the company’s long-term vision.
How to Buy Anthem Biosciences Shares?
You can purchase Anthem Biosciences shares through any major online stock trading platform:
- Zerodha
- Angel One
- Groww
- Dhan
- Upstox
- PhonePe Share Market App
Just search for “ANTHEM” on the NSE or BSE.
Conclusion
Anthem Biosciences is a rapidly growing CRISP company with robust research facilities and a strong global client base. If you’re looking for long-term value in the biotech and pharma contract services space, Anthem is worth considering.
With projected share price targets ranging from ₹730 in 2025 to ₹1,300 by 2030, investors can expect healthy capital appreciation—provided the company maintains growth momentum and operational excellence.
Frequently Asked Questions – Anthem Biosciences Share Price Target
Q1. What is the share price target of Anthem Biosciences Ltd for 2025?
A: Based on expert analysis, the share price target for Anthem Biosciences Ltd in 2025 is projected to be in the range of ₹[insert low-end] to ₹[insert high-end], depending on market performance and business growth.
Q2. What is the forecast for Anthem Biosciences share price by 2030?
A: By 2030, Anthem Biosciences Ltd is expected to show steady growth with a share price target of ₹[insert predicted range], driven by global demand for pharmaceutical R&D and biotech services.
Q3. Is Anthem Biosciences a listed company?
A: As of now, Anthem Biosciences Ltd is [insert current status – either “not listed yet but planning for IPO” or “a publicly listed company on NSE/BSE”].
Q4. What does Anthem Biosciences Ltd do?
A: Anthem Biosciences is a contract research and manufacturing services (CRAMS) company specializing in pharmaceutical, biotechnology, and chemical research services for global clients.
Q5. Is Anthem Biosciences Ltd planning an IPO?
A: Yes, Anthem Biosciences is expected to launch its IPO soon. Investors are closely watching for updates on the DRHP and official IPO timeline.
Q6. What are the growth drivers for Anthem Biosciences?
A: The company benefits from increasing global outsourcing in pharma R&D, expansion in the CRAMS market, and consistent investment in infrastructure and capabilities.
Q7. Should I invest in Anthem Biosciences for long term?
A: Long-term investment decisions should be based on company fundamentals, revenue growth, competitive position, and industry trends. Always consult with a financial advisor before investing.
Disclaimer
The share price targets and forecasts for Anthem Biosciences Ltd mentioned in this article are based on publicly available information, market analysis, and expert opinions. These projections are for educational and informational purposes only and should not be considered as investment advice or stock recommendations. Stock market investments are subject to market risks. Please consult your financial advisor before making any investment decisions. The website upcomingipowatch.in is not liable for any financial losses or gains arising from the use of this information.
